Anti-APOC4/ APO-CIV/ APOC-IV functional antibody

Anti-APOC4/ APO-CIV/ APOC-IV functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to APOC4/APOC4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0674-Ab-1/ GM-Tg-hg-SE0674-Ab-2Anti-Human APOC4 monoclonal antibodyHuman
GM-Tg-rg-SE0674-Ab-1/ GM-Tg-rg-SE0674-Ab-2Anti-Rat APOC4 monoclonal antibodyRat
GM-Tg-mg-SE0674-Ab-1/ GM-Tg-mg-SE0674-Ab-2Anti-Mouse APOC4 monoclonal antibodyMouse
GM-Tg-cynog-SE0674-Ab-1/ GM-Tg-cynog-SE0674-Ab-2Anti-Cynomolgus/ Rhesus macaque APOC4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0674-Ab-1/ GM-Tg-felg-SE0674-Ab-2Anti-Feline APOC4 monoclonal antibodyFeline
GM-Tg-cang-SE0674-Ab-1/ GM-Tg-cang-SE0674-Ab-2Anti-Canine APOC4 monoclonal antibodyCanine
GM-Tg-bovg-SE0674-Ab-1/ GM-Tg-bovg-SE0674-Ab-2Anti-Bovine APOC4 monoclonal antibodyBovine
GM-Tg-equg-SE0674-Ab-1/ GM-Tg-equg-SE0674-Ab-2Anti-Equine APOC4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0674-Ab-1/ GM-Tg-hg-SE0674-Ab-2; GM-Tg-rg-SE0674-Ab-1/ GM-Tg-rg-SE0674-Ab-2;
GM-Tg-mg-SE0674-Ab-1/ GM-Tg-mg-SE0674-Ab-2; GM-Tg-cynog-SE0674-Ab-1/ GM-Tg-cynog-SE0674-Ab-2;
GM-Tg-felg-SE0674-Ab-1/ GM-Tg-felg-SE0674-Ab-2; GM-Tg-cang-SE0674-Ab-1/ GM-Tg-cang-SE0674-Ab-2;
GM-Tg-bovg-SE0674-Ab-1/ GM-Tg-bovg-SE0674-Ab-2; GM-Tg-equg-SE0674-Ab-1/ GM-Tg-equg-SE0674-Ab-2
Products NameAnti-APOC4 monoclonal antibody
Formatmab
Target NameAPOC4
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-APOC4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0674-Ag-1Recombinant multi-species APOC4/ APO-CIV/ APOC-IV protein


    Target information

    Target IDGM-SE0674
    Target NameAPOC4
    Gene ID346,11425,680551,718319,111097895,101086270,618041,100065506
    Gene Symbol and SynonymsAcl,APO-CIV,APOC-IV,APOC4
    Uniprot AccessionP55056,P55797,Q3SYR5
    Uniprot Entry NameAPOC4_HUMAN,APOC4_RAT,APOC4_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOvary Cancer, IgA glomerulonephritis
    Gene EnsemblENSG00000267467
    Target ClassificationN/A

    The target: APOC4, gene name: APOC4, also named as APO-CIV, APOC-IV. This gene encodes a lipid-binding protein belonging to the apolipoprotein gene family. The protein is thought to play a role in lipid metabolism. Polymorphisms in this gene may influence circulating lipid levels and may be associated with coronary artery disease risk. This gene is present in a cluster with other related apolipoprotein genes on chromosome 19. Naturally occurring read-through transcription exists between this gene and the neighboring downstream apolipoprotein C-II (APOC2) gene. [provided by RefSeq, Mar 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.